Trials / Completed
CompletedNCT05328479
Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand
The Study of Treatment Outcome and Immunogenicity of mild-to Moderate COVID-19 Patients During the Delta vs. the Omicron Pandemic
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,181 (actual)
- Sponsor
- Mahidol University · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.
Detailed description
The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.
Conditions
Timeline
- Start date
- 2021-11-04
- Primary completion
- 2022-03-15
- Completion
- 2022-05-20
- First posted
- 2022-04-14
- Last updated
- 2022-10-19
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05328479. Inclusion in this directory is not an endorsement.